Eurofins Scientific acquires Dermatest
Select language to see a machine translation of this article. The original language of the Article is English and the translation is provided for your convenience.

Eurofins Scientific acquires Dermatest

Worldwide laboratory group Eurofins Scientific has acquired Australian sunscreen and skin care evaluation laboratory Dermatest. Announcing the acquisition at the end of August, Eurofins said that it hopes to use its experience providing analytic testing services to the pharmaceutical, environmental, and consumer industries to help raise Dermatest’s profile in the Australian and Asia Pacific markets.

Eurofins share price has risen by 21% in 2017, year to date

eurofins1109

SOURCE: Yahoo Finance

Dermatest was established in 1997, and in the years since, it has become Australia’s leading sunscreen and skin care evaluation laboratory. According to Eurofins, both the company and its CEO, John Stanton, are highly regarded in the sun protection field. Yann Augustin, Eurofins’ consumer products testing managing director for South Europe, said:

Apart from providing Eurofins with a very good entry into the cosmetic testing market in Australia, Dermatest will allow Eurofins to become the worldwide reference in sunscreen testing, increasing our portfolio and strengthening our current expertise and capabilities in Europe. We are eager to contribute to Dermatest’s development position in itsmarket, as well as expanding the portfolio of tests it offers to customers by offering the full range of services and capabilities of the Eurofins network.

Disclosure

Dominion holds Eurofins Scientific in its Global Trends Managed Fund.


If you would you like to receive the Newsfeeds daily, please click here to sign up now!

Help us make this Newsfeed better by rating this article. 1 star = Poor and 5 stars = Excellent
0.0/5 rating (0 votes)

Disclaimer
The views expressed in this article are those of the author at the date of publication and not necessarily those of Dominion Fund Management Limited. The content of this article is not intended as investment advice and will not be updated after publication. Images, video, quotations from literature and any such material which may be subject to copyright is reproduced in whole or in part in this article on the basis of Fair use as applied to news reporting and journalistic comment on events.